Market Alert: Ceasefire Hopes Between Israel and Iran Falter, Renewing Market Volatility

Objective Corporation acquires Isovist to enhance Gov. Tech capabilities.

Jul 01, 2025

Objective Corporation (ASX: OCL) has announced the acquisition of Isovist, a leading provider of GIS-based e-planning solutions for local governments in Australia and New Zealand. This strategic acquisition strengthens Objective’s presence in the planning and building sector by integrating Isovist’s user-friendly, dynamic planning tools that transform traditional manual processes. Isovist’s platform is widely used across more than 50 councils and is praised for its intuitive design, fast deployment, and deep alignment with local planning frameworks.

The acquisition, valued at NZ$5 million (NZ$4.25 million upfront and NZ$0.75 million deferred), will be paid entirely in cash. Isovist reported an ARR of NZ$2.2 million as of June 2025 and has been profitable since 2022. All employees will join Objective. The integration of Objective’s advanced AI capabilities with Isovist’s platform aims to further innovate and streamline planning processes, enhancing decision-making and efficiency for councils and developers alike.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com